Crescent Biopharma, Inc. (CBIO) Stock Price & Analysis
Crescent Biopharma, Inc. (CBIO) rose 2.35% to USD 20.88 as of September 8, 2026 at 08:18 UTC, according to Nexqual real-time market data.
CBIO last closed at USD 20.88; the session ranged USD 20.09–21.53 on volume of 239,695 shares. Market capitalization is —, with a 52-week range of USD 8.72–27.41 (NCM). Source: Nexqual, September 8, 2026 at 08:18 UTC.
Key Statistics (as of September 8, 2026 at 08:18 UTC)
| Price | USD 20.88 |
|---|---|
| Change | ▲ 2.35% (up) |
| Previous Close | USD 20.88 |
| Open | USD 20.88 |
| Day Range | USD 20.09 – 21.53 |
| 52-Week Range | USD 8.72 – 27.41 |
| Volume | 239,695 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CBIO)
Nexqual's technical model rates CBIO "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 08:18 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.17 (neutral) |
| vs SMA50 | Above (USD 16.8) |
| MACD | 0.77 (positive) |
From Crescent Biopharma, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Partnerships
- We recently announced a partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun"), a leading Chinese biotech company with commercially approved ADCs, to acquire exclusive rights to SKB105 (also referred to as CR-003), an integrin beta-6 ("ITGB6")-directed ADC, outside of mainland China, Hong Kong, Macau, and Taiwan (collectively, "Greater China").
- The potential to combine CR-001 with ADCs is a key element of our partnership with Kelun.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | USD 12.68 | ▼ 1.55% |
| AKTX | Akari Therapeutics Plc | USD 11.47 | ▲ 13% |
| PULM | Pulmatrix, Inc. | USD 1.39 | ▼ 5.44% |
| CLRB | Cellectar Biosciences, Inc. | USD 2.37 | ▼ 2.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:18 UTC. This page is informational and not investment advice.